TVM Capital Healthcare’s $17 Million Boost To Neurocare Aims At Mental Health Care Global Expansion

In a significant move to enhance mental health care globally, TVM Capital Healthcare, a specialist healthcare private equity firm based in Dubai and Singapore, has made a substantial investment into neurocare group AG. The Munich-headquartered innovator in personalized mental health care will receive a US$ 17 million boost from TVM Capital Healthcare. This financial backing is aimed at propelling neurocare's international expansion, with a focus on penetrating the US market and establishing a presence in the Kingdom of Saudi Arabia. Additionally, the funds will support the development of new hardware and software innovations, marking it as the ninth investment by TVM Capital Healthcare to improve access to quality healthcare in the MENA region.

neurocare stands out for its digital therapy platform (DTP), which offers a comprehensive and patient-centric treatment approach for various psychological and neurological conditions. The company leverages advanced mental health care methods such as sleep assessment, therapeutics, psychotherapy, TMS (Transcranial Magnetic Stimulation), and neurofeedback. These tools are integrated within a cloud-based solution, enabling clinicians to deliver personalized care. neurocare's methods have been instrumental in crafting individualized therapy plans that aim for strong and sustainable clinical outcomes. The company's innovative offerings are utilized in its clinics across the US, Europe, and Australia, as well as in an increasing number of third-party clinics.

Addressing a Growing Global Need

According to the World Health Organization, 13.0% of the global population is affected by mental disorders. These conditions inflict significant direct and indirect costs, which are predicted to rise from $2.5 trillion in 2010 to $6 trillion by 2030. The COVID pandemic has exacerbated the situation, doubling the number of patients diagnosed with mental illnesses. Despite the growing need, treatment for mental health conditions is severely lacking in most countries, leaving a considerable portion of the population without necessary support. This gap presents a prime opportunity for entities like neurocare, which offer innovative, non-invasive treatments that promise superior clinical outcomes.

A Strategic Investment for Regional Healthcare Improvement

Tristan de Boysson, Managing Partner at TVM Capital Healthcare, emphasized the strategic nature of the investment. He highlighted the company's objective to enhance healthcare infrastructure in Saudi Arabia and the broader MENA region. Boisson pointed out that most mental health clinics in the region currently rely on traditional care therapy methods. Thus, introducing neurocare's innovative treatments could significantly improve mental health outcomes. "We are excited about bringing this offering to the people in the MENA Region," Boisson remarked, indicating a positive outlook for the partnership with neurocare.

Thomas Mechtersheimer, Founder and CEO of neurocare group, expressed his enthusiasm for the partnership with TVM Capital Healthcare, noting its potential to accelerate neurocare's growth in key markets and expand into new regions. He acknowledged the significance of implementing the Digital Therapy Platform in the MENA region as a milestone in the company's growth and thanked all parties involved for their support in finalizing the financing agreement.

The collaboration between TVM Capital Healthcare and neurocare group AG marks a pivotal step towards addressing the critical gap in mental health care provision. With a focus on innovation and quality care, this partnership is poised to make a significant impact on mental health treatment standards globally, particularly in underserved regions like the MENA area.